Comparison of 2 Different Methods in Infraclavicular Block
Launched by ANKARA CITY HOSPITAL BILKENT · May 2, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Background : The investigators to see if dexamethasone, which is routinely used as an adjuvant tool by different anesthesiologists in the orthopedics operating room, can really start the effect of other local anesthetics early and prolong the duration of action during infraclavicular block, thus enabling the surgery to start early and giving less additional analgesics after surgery.
Aims:The investigators plan to determine whether this outcome of dexamethasone , which is routinely used as an adjuvant tool to prolong postoperative analgesia.
Methods :60 participants will be included in the...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ASA I-III patient group who will undergo upper extremity surgery will be included in the study.
- Exclusion Criteria:
- • Patients under the age of 18 who have lung diseases that will prevent blocking and who are not mentally healthy will not be included in the study.
About Ankara City Hospital Bilkent
Ankara City Hospital Bilkent is a leading healthcare institution in Turkey, dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Equipped with state-of-the-art facilities and a multidisciplinary team of experienced professionals, the hospital fosters a collaborative environment for conducting rigorous scientific investigations. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of integrity, ultimately contributing to the development of new therapies and enhancing the quality of care provided to patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, çankaya, Turkey
Ankara, , Turkey
Patients applied
Trial Officials
Esma M Simsek, M.D.
Principal Investigator
Ankara City Hospital Bilkent
Hülya Kaşıkara, M.D.
Study Director
Ankara City Hospital Bilkent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported